Browse By

Tag Archives: Medical Cannabis

Curaleaf Receives Clinical Registrant Designation by the Pennsylvania Department of Health

National Cannabis Leader will be Part of State’s First-in-the-Nation Research Program and Help Shape the Future of Medical Cannabis Treatment PHILADELPHIA, Feb. 21, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, has been approved

MediPharm Labs to Supply Medical Cannabis Products to Medical Cannabis by Shoppers

BARRIE, Ontario, Feb. 20, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce Shoppers Drug Mart, Canada’s leading pharmacy

James E. Wagner Cultivation Reaches Supply Agreement with OCS and Prepares to Launch Products into Recreational Market

KITCHENER, Ontario, Feb. 19, 2020 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX: JWCA.V; OTCQX: JWCAF), has entered into a Master Cannabis Supply Agreement effective February 6, 2020, with the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). This

Curaleaf to Report Fourth Quarter and Fiscal Year 2019 Financial and Operational Results

WAKEFIELD, Mass., Feb. 18, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2019 after

AgraFlora Subsidiary Farmako Receives Special License Permitting the Sale of Irradiated Medical Cannabis

VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce that the Company’s wholly owned subsidiary, Farmako GmbH (“Farmako”) has secured a special

Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC

TORONTO, Feb. 14, 2020 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce it will be participating in the 3rd Annual Gravitas Growth Conference taking place February 20th, 2020 at the